Revenue (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

The following table presents the Company’s revenues disaggregated by geographical region and revenue type ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.


	Biotechnology		Life Sciences		Diagnostics		Total
Year ended December 31, 2024:
Geographical region:
North America(a)	$	2,237	$	3,199	$	4,859	$	10,295
Western Europe	2,296		1,574		1,587		5,457
Other developed markets(b)	335		510		408		1,253
High-growth markets(c)	1,891		2,046		2,933		6,870
Total	$	6,759	$	7,329	$	9,787	$	23,875

Revenue type:
Recurring	$	5,758	$	4,889	$	8,719	$	19,366
Nonrecurring	1,001		2,440		1,068		4,509
Total	$	6,759	$	7,329	$	9,787	$	23,875

Year ended December 31, 2023:
Geographical region:
North America(a)	$	2,454	$	2,999	$	4,508	$	9,961
Western Europe	2,407		1,519		1,542		5,468
Other developed markets(b)	329		510		431		1,270
High-growth markets(c)	1,982		2,113		3,096		7,191
Total	$	7,172	$	7,141	$	9,577	$	23,890

Revenue type:
Recurring	$	5,897	$	4,360	$	8,425	$	18,682
Nonrecurring	1,275		2,781		1,152		5,208
Total	$	7,172	$	7,141	$	9,577	$	23,890

Year ended December 31, 2022:
Geographical region:
North America(a)	$	3,054	$	3,154	$	5,522	$	11,730
Western Europe	2,645		1,377		1,837		5,859
Other developed markets(b)	358		506		481		1,345
High-growth markets(c)	2,701		1,999		3,009		7,709
Total	$	8,758	$	7,036	$	10,849	$	26,643

Revenue type:
Recurring	$	6,958	$	4,220	$	9,698	$	20,876
Nonrecurring	1,800		2,816		1,151		5,767
Total	$	8,758	$	7,036	$	10,849	$	26,643

(a) The Company defines North America as the United States and Canada.

(b) The Company defines other developed markets as all the markets of the world that are not North America, Western Europe or high-growth markets.

(c) The Company defines high-growth markets as Eastern Europe, the Middle East, Africa, Latin America (including Mexico) and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets of the world that are not high-growth markets.